Skip to main content

Drug Safety

    The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020. Watch now!
    Rheumatology Round-Up with Drs. Kavanaugh & Cush

    The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.

    RT @TheLancet: Latebreaking at #ACR20—Febuxostat was non-inferior to allopurinol with regard to the occurrence of majo
    3 years 3 months ago
    Latebreaking at #ACR20—Febuxostat was non-inferior to allopurinol with regard to the occurrence of major cardiovascular outcomes in patients with gout: finding from FAST, multicentre, prospective, randomised, open-label, non-inferiority trial https://t.co/cpoNi7zjwi https://t.co/uQyeyepPmj
    Febuxostat, a nonpurine xanthine oxidase inhibitor used in the treatment of chronic gout to lower serum urate levels, received bad press in 2019 after the US Food and Drug Administration (FDA) placed…
    As we inch closer to a possible vaccine for COVID-19, we are finally filling in the details on how the pandemic is affecting every aspect of our patient’s lives. Are our rheumatic patients at…
    New ACR RA Guidelines and Practice Changing Abstracts: RA Panel

    Dr. Jonathan Kay leads an international panel on the new ACR RA guidelines and other practice-changing abstracts presented at the 2020 ACR annual meeting. Panelists include Dr.Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes. 

    Cardiovascular Safety for Feboxustat with Dr. Nicola Dalbeth

    Auckland's Dr. Dalbeth examines the cardiovascular safety in the FAST trial of feboxustat (abstract L08) presented at the ACR 2020.

    Adverse Events in Low-Dose Methotexate: Dr. Eric Dein

    Dr. Eric Dein reviews abstract #2001 presented at the 2020 ACR annual meeting. 

    Dr. Tom Appleton and Dr. Peter Nash Highlight OA and PsA Studies

    Dr. Janet Pope interviews Dr. Tom Appleton and Dr. Peter Nash about several osteoarthritis and psoriatic arthritis studies presented at the 2020 ACR annual meeting.